Exclusive

Publication

Byline

State of Tennessee Department Of Revenue Issues Solicitation Notice for Unclaimed Vehicle Portal

Nashville, Tenn., Sept. 3 -- The State of Tennessee Department Of Revenue (34717-01017) for Unclaimed Vehicle Portal. Description: The State is looking for a single, experienced vendor to implement ... Read More


President Prabowo witnesses US$22.6 billion in Indonesia-Japan deals

Jakarta, March 31 -- Indonesian President Prabowo Subianto witnessed the announcement of 10 memoranda of understanding (MoUs) and agreements between Indonesian and Japanese business players worth US$2... Read More


Six militants nabbed in Manipur

Imphal, March 31 -- In a series of operations conducted in Manipur, security forces have arrested six militants. Published by HT Digital Content Services with permission from United News of India.... Read More


Shah Rukh's closeness with BJP increasing

Bangladesh, March 31 -- Bollywood superstar Shah Rukh Khan's presence at a family function of an Indian BJP leader has sparked a new social media frenzy. The actor, who has always maintained a distan... Read More


Mustafiz shines despite Lahore lose to Karachi in PSL

Bangladesh, March 31 -- Lahore Qalandars lost to Karachi Kings by 4 wickets in the second match of the day in the Pakistan Super League (PSL) on Sunday. However, Mustafizur Rahman once again shone wit... Read More


Bhumi: వయసు పెరుగుతోంది, అందుకే నా శరీరంపై ఫోకస్ పెట్టాను.. వెయిట్ లాస్ ట్రోల్స్‌పై స్టార్ హీరోయిన్ భూమి కామెంట్స్

భారతదేశం, మార్చి 31 -- బాలీవుడ్ వెర్సటైల్ హీరోయిన్ భూమి పెడ్నేకర్ తన కెరీర్ ఆరంభం నుంచి బాడీ ట్రాన్స్‌ఫార్మేషన్ విషయంలో వార్తల్లో నిలుస్తూనే ఉన్నారు. తొలి సినిమా 'దమ్ లగా కే హయిషా' కోసం భారీగా బరువు ప... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More


Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More